
Sign up to save your podcasts
Or


In the October 29, 2024 issue of JACC, Dr. Valentin Fuster explores groundbreaking studies on heart failure treatments, including the impact of sacubitril-valsartan on hypotension, the benefits of intravenous iron for reducing hospitalizations, the prognostic value of platelet FCγRIIA in post-myocardial infarction patients, and innovative AI assessments of environmental factors influencing cardiovascular risk.
By American College of Cardiology4.2
162162 ratings
In the October 29, 2024 issue of JACC, Dr. Valentin Fuster explores groundbreaking studies on heart failure treatments, including the impact of sacubitril-valsartan on hypotension, the benefits of intravenous iron for reducing hospitalizations, the prognostic value of platelet FCγRIIA in post-myocardial infarction patients, and innovative AI assessments of environmental factors influencing cardiovascular risk.

138 Listeners

319 Listeners

503 Listeners

897 Listeners

20 Listeners

30 Listeners

3,383 Listeners

136 Listeners

1,150 Listeners

63 Listeners

39 Listeners

197 Listeners

92 Listeners

377 Listeners

435 Listeners